Cargando…
The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery followed by adjuvant chemotherapy represents the only curative option which, unfortunately, is only available for a small group of patients. The majority of pancreatic cancer cases are diagnosed at advanced or me...
Autores principales: | Garcia-Sampedro, Andres, Gaggia, Gabriella, Ney, Alexander, Mahamed, Ismahan, Acedo, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913382/ https://www.ncbi.nlm.nih.gov/pubmed/33546207 http://dx.doi.org/10.3390/jcm10040566 |
Ejemplares similares
-
Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum
por: Ney, Alexander, et al.
Publicado: (2021) -
DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021) -
State of the Art in Exocrine Pancreatic Insufficiency
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020) -
State-of-the-art surgery for pancreatic cancer
por: Nießen, Anna, et al.
Publicado: (2021) -
State-of-the-Art Update of Pancreatic Cysts
por: Canakis, Andrew, et al.
Publicado: (2021)